RxDoctor Payments DataLook up a doctor →

Aremmia Tanious, MD

Neurology · Laurel, MSNPI 1184638033

Payments from drug & device makers

$52,576in general payments, 2019–2025

Across 883 payments — averaging $59.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$40K
  • Acadia Pharmaceuticals Inc$1K
  • SK Life Science, Inc.$1K
  • Pfizer$871
  • Lilly USA, LLC$751
  • Teva Pharmaceuticals USA, Inc.$644
  • plus $9K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)162$39,609
Acadia Pharmaceuticals Inc61$1,097
SK Life Science, Inc.54$1,086
Pfizer55$871
Lilly USA, LLC55$751
Teva Pharmaceuticals USA, Inc.41$644
Sunovion Pharmaceuticals Inc.36$538
UCB, Inc.27$510
ANI Pharmaceuticals, Inc.9$493
Eisai Inc.21$412
Upsher-smith Laboratories LLC26$390
Takeda Pharmaceuticals U.S.A., Inc.22$372
Otsuka America Pharmaceutical, Inc.15$357
Octapharma USA, Inc.16$344
Adamas Pharmaceuticals, Inc.17$320
Sanofi17$282
Supernus Pharmaceuticals, Inc.17$279
Novartis16$268
Johnson & Johnson(2 entities)14$259
Biohaven Pharmaceuticals, Inc.14$246
Argenx US, Inc.12$239
Amgen14$230
Avanir Pharmaceuticals, Inc.16$212
Lundbeck LLC13$210
Harmony Biosciences LLC8$206
Biohaven Pharmaceutical Holding Company Ltd.11$205
GE HealthCare10$193
Sumitomo Pharma America, Inc.9$174
Neurocrine Biosciences, Inc.8$153
Neuronetics, Inc.5$152
Biogen8$132
Inspire Medical Systems, Inc.4$131
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$121
AstraZeneca7$117
Idorsia Pharmaceuticals US Inc5$92
MDD US Operations, LLC5$86
Jazz Pharmaceuticals Inc.4$73
Corium, LLC4$72
Catalyst Pharmaceuticals, Inc.4$71
Genentech USA, Inc.4$67
Valinor Pharma, LLC4$67
Neurelis, Inc.2$52
Vanda Pharmaceuticals Inc.3$47
Axsome Therapeutics, Inc.2$45
Shire North American Group Inc3$43
Itamar Medical Inc1$34
Alkermes, Inc.1$24
Averitas Pharma Inc.1$20
Merz Pharmaceuticals, LLC1$19
Impel Pharmaceuticals Inc.1$17
Kowa Pharmaceuticals America, Inc.1$17
Greenwich Biosciences, Inc.1$16
Scilex Pharmaceuticals Inc.1$16
E.r. Squibb & Sons, L.L.C.1$15
GRT US Holding, Inc.1$15
Medtronic1$14
Vertos Medical, Inc.1$14
Merck1$14
Arbor Pharmaceuticals, Inc.1$13
Sanofi-aventis U.S. LLC1$12

How this compares

$52,576 in reported general payments places this provider in the 85th percentile of 111 neurology providers in Mississippi.

See all neurology providers in Mississippi

Medicare billing

Part B allowed, 2024
$209,941
Medicare patients
578
Services billed
5,678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Laurel

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →